Current treatment status-Currently treated-Monotherapy with another drug (not MTX) Posts on Medivizor
Navigation Menu

Current treatment status-Currently treated-Monotherapy with another drug (not MTX) Posts on Medivizor

SB2: a safe and effective switch from infliximab for patients with rheumatoid arthritis?

SB2: a safe and effective switch from infliximab for patients with rheumatoid arthritis?

Posted by on Dec 4, 2017 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated the safety and effectiveness of switching to SB2 from infliximab (Remicade) in patients with rheumatoid arthritis. They found that switching to SB2 from infliximab was well tolerated and effective at reducing disease activity. Some background Rheumatoid arthritis (RA) is a chronic disease that causes...

Read More

Non-steroidal anti-inflammatory drugs in rheumatic patients: the impact on the gastrointestinal tract

Posted by on Jun 7, 2015 in Rheumatoid Arthritis | 0 comments

In a nutshell This study examined the frequency of gastrointestinal (digestive tract) events in at-risk rheumatic patients using non-steroidal anti-inflammatory drugs. Some background Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen (Advil) are used to relieve pain in patients with rheumatic diseases. However, they can also cause...

Read More

Identifying rheumatoid arthritis patients that are suitable for a lower dose of anti-TNF alpha therapy

Posted by on Jun 1, 2015 in Rheumatoid Arthritis | 0 comments

In a nutshell This study examined whether a combination of clinical and ultrasound assessments could identify rheumatoid arthritis patients suitable for a lower dose of anti-TNF alpha therapy.  Some background Anti-TNF alpha therapy (Humira, Enbrel, Remicade and Cimzia) is used to treat patients who have a severe form of rheumatoid...

Read More

Is subcutaneous injection of Actemra safe and effective in rheumatoid arthritis patients?

Is subcutaneous injection of Actemra safe and effective in rheumatoid arthritis patients?

Posted by on May 18, 2015 in Rheumatoid Arthritis | 0 comments

In a nutshell This study examined the safety and effectiveness of switching from intravenous tocilizumab (Actemra) to subcutaneous. Some background Tocilizumab is a drug which prevents the immune system from attacking the joints in rheumatoid arthritis patients. It is given intravenously (injected into a vein by a healthcare...

Read More

A new model to predict effectiveness of infliximab (Remicade) in rheumatoid arthritis patients

A new model to predict effectiveness of infliximab (Remicade) in rheumatoid arthritis patients

Posted by on Apr 21, 2015 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated whether doctors could predict the long term effectiveness of infliximab (Remicade) treatment for rheumatoid arthritis, based on early results at 3 months.  Some background Rheumatoid arthritis is an autoimmune disease, caused by the immune system attacking healthy tissue. Blocking the immune system...

Read More